Chardan Downgrades Synlogic Inc. (SYBX) to Neutral 'on Early Termination of Synpheny-3 Trial' Feb 9, 2024 07:48AM
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering Oct 3, 2023 04:15PM
Synlogic (SYBX) Prices 7.39M Share Offering at $2.84/sh Sep 29, 2023 07:00AM
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering Sep 29, 2023 07:00AM
Synlogic to Participate in Chardan’s Genetic Medicines Conference Sep 21, 2023 07:00AM


Feb 24, 2022 07:00AM Synlogic To Present at Upcoming Investor and Industry Conferences
Sep 23, 2021 05:45AM Synlogic (SYBX) Prices 15M Share Stock Offering at $3/sh
Sep 22, 2021 11:32PM Synlogic Announces Pricing of Public Offering of Common Stock
Feb 15, 2021 07:00AM Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
Mar 11, 2020 04:02PM Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit
Sep 30, 2019 04:02PM Synlogic to Present at the Chardan 3rd Annual Genetic Medicines Conference
Aug 20, 2019 09:53AM UPDATE: Synlogic Inc. (SYBX) PT Lowered to $9.50 at Chardan
Jul 15, 2019 09:42AM Synlogic Inc. (SYBX) PT Raised to Street High $25 at Chardan Capital Markets
Feb 28, 2019 05:00PM Synlogic to Present at Investor Conferences in March
Dec 13, 2018 06:43AM UPDATE: Chardan Capital Markets Starts Synlogic Inc. (SYBX) at Buy